Clinical Trials
27 trialsGene Therapy Follow up Protocol for Subjects Previously Enrolled in NCI Center for Immuno-Oncology Studies
National Institutes of Health Clinical Center (CC)
CASCADE3002
UNC Lineberger Comprehensive Cancer Center
TRUST-GB
Centre Paul Strauss
BARHYSTER
Aesculap AG
DP-04
AstraZeneca
Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors
University of Southern California
Peripheral Blood CyTOF Immune Model for Cervical Lesion Detection in HPV16/18+ Women
Women's Hospital School Of Medicine Zhejiang University
Quality of Life and Sexuality After Pelvic Exenteration for Gynecologic Cancer
Tampere University Hospital
COLTEP
University Hospital, Brest
OvAR-Y
Washington University School of Medicine
PRIORITY
Pontificia Universidad Catolica de Chile
SURVIMON
N.N. Petrov National Medical Research Center of Oncology
Blood and Urine HPVDNA as Minimally Invasive Biomarkers for Cervical Cancer Detection and Surveillance Following Treatment
UNC Lineberger Comprehensive Cancer Center
Bio-CHECC
University of Manchester
GEORGIA
Ohio State University Comprehensive Cancer Center
Prevention and Early Detection of Cervical Cancer Through Self-Administered Screening
University of California, San Francisco
HPV FOCAL
University of British Columbia
A Pilot Study of Quantitative Tumor Oxygen Measurements in Cervical Cancer
Brigham and Women's Hospital
ECHO
Mayo Clinic
Infertility Survey Among Reproductive Age Women With Gynecological and Breast Cancer
M.D. Anderson Cancer Center
TraveraRTGx
Travera Inc
ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
AstraZeneca
HPV-Vac-S
International Agency for Research on Cancer
PaPCR
University Hospital, Brest
Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC
AIDS Malignancy Consortium
HART
General University Hospital, Prague
Paclitaxel Therapeutic Drug Monitoring in Cancer Patients
Wake Forest University Health Sciences